BiomX Inc (PHGE) Q3 2024 Earnings Call Highlights: Strong Net Income Amid Rising Expenses

By Yahoo! Finance | 1 month ago

BiomX expects top-line results for BX 201 trial in Q1 2025 and BX 004 in H1 2026. The company has $24.7M in funds, expected to last until Q4 2025.

Did you find this insightful?

Bad

Just Okay

Amazing

Select an alert type